1994
DOI: 10.1016/s0021-9258(17)34105-4
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal absorption of peptides by coupling to bile acids.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

1996
1996
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(16 citation statements)
references
References 39 publications
0
16
0
Order By: Relevance
“…Despite a large portion of their research focusing on the transporters in hepatocytes, they made great achievements in promoting drug absorption by ASBT as well. For example, they modified cholic acid at C 3 and C 24 to synthesize 3β-(ωaminoalkoxy)-7α, l2α-dihydroxy-5β-cholan-24-oic acid, conjugated it with peptides of different chain lengths, and tested their absorption after ileum perfusion in rats [112,113]. It was found that [ 3 H] taurocholate uptake was significantly reduced when incubated with hybrid peptides containing more than four amino acid residues.…”
Section: Bile Acid-conjugated Prodrug Strategymentioning
confidence: 99%
“…Despite a large portion of their research focusing on the transporters in hepatocytes, they made great achievements in promoting drug absorption by ASBT as well. For example, they modified cholic acid at C 3 and C 24 to synthesize 3β-(ωaminoalkoxy)-7α, l2α-dihydroxy-5β-cholan-24-oic acid, conjugated it with peptides of different chain lengths, and tested their absorption after ileum perfusion in rats [112,113]. It was found that [ 3 H] taurocholate uptake was significantly reduced when incubated with hybrid peptides containing more than four amino acid residues.…”
Section: Bile Acid-conjugated Prodrug Strategymentioning
confidence: 99%
“…The oligopeptides may be made enterally absorbable by coupling to modified bile acid molecules making use of the specific Na + /ileal acid cotransporter. This finding may be of importance for the design and development of orally active peptide drugs (Kramer et al, 1994).…”
Section: Bile Acid Transportermentioning
confidence: 75%
“…Inhibition of [ 14 C]TCA Transport by Bile Acid − Peptide Conjugates. The CaCo-2 cell system was chosen for this study because these cells functionally express the bile acid transporter ( , ). Since maximal expression of this carrier occurs after 21 days after seeding on transwell membranes, all experiments were carried with cells cultured for 21−28 days.…”
Section: Resultsmentioning
confidence: 99%
“…They showed that their conjugates were able to bind to the intestinal bile acid transporter but were not transported in vivo. More recently, Kramer and colleagues used modifications at the 3-position for liver specific targeting of chlorambucil (5), HMG-CoA reductase inhibitors (6), and small peptides up to 4 amino acids (7). The essential molecular requirement for active bile acid absorption is the retention of an acidic moiety around the 24-position on the sterol nucleus.…”
Section: Introductionmentioning
confidence: 99%